Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Neuronal acetylcholine receptor subunit alpha-6 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable oxalyl-CoA decarboxylase OxcA | 0.0224 | 0.34 | 1 |
Mycobacterium ulcerans | pyruvate or indole-3-pyruvate decarboxylase Pdc | 0.0128 | 0.1251 | 0.368 |
Loa Loa (eye worm) | hypothetical protein | 0.0519 | 1 | 1 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0073 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0519 | 1 | 1 |
Brugia malayi | Glycogen synthase | 0.0212 | 0.3128 | 0.2405 |
Giardia lamblia | Glycogen synthase, putative | 0.0519 | 1 | 0.5 |
Echinococcus granulosus | glycogen synthase | 0.0519 | 1 | 1 |
Loa Loa (eye worm) | ILVBL protein | 0.0136 | 0.1418 | 0.0516 |
Schistosoma mansoni | glycogen synthase | 0.0519 | 1 | 1 |
Mycobacterium leprae | Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) | 0.0224 | 0.34 | 0.5 |
Echinococcus multilocularis | glycogen synthase | 0.0519 | 1 | 1 |
Leishmania major | putative pyruvate/indole-pyruvate carboxylase, putative | 0.0128 | 0.1251 | 1 |
Loa Loa (eye worm) | thiamine pyrophosphate enzyme | 0.0129 | 0.1256 | 0.0337 |
Brugia malayi | Thiamine pyrophosphate enzyme, central domain containing protein | 0.0224 | 0.34 | 0.2706 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0128 | 0.1251 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0519 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0519 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0224 | 0.34 | 1 |
Mycobacterium ulcerans | putative oxalyl-CoA decarboxylase | 0.0224 | 0.34 | 1 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0073 | 0 | 0.5 |
Mycobacterium ulcerans | acetolactate synthase | 0.0128 | 0.1251 | 0.368 |
Loa Loa (eye worm) | hypothetical protein | 0.0519 | 1 | 1 |
Mycobacterium ulcerans | acetolactate synthase large subunit IlvB | 0.0128 | 0.1251 | 0.368 |
Loa Loa (eye worm) | glycogen synthase | 0.0212 | 0.3128 | 0.2405 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 0.3128 | 0.2405 |
Mycobacterium tuberculosis | Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) | 0.0224 | 0.34 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0128 | 0.1251 | 0.5 |
Brugia malayi | Glycogen synthase | 0.0212 | 0.3128 | 0.2405 |
Onchocerca volvulus | Glycogen synthase homolog | 0.0519 | 1 | 1 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0073 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) | 0.0224 | 0.34 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0519 | 1 | 1 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0073 | 0 | 0.5 |
Mycobacterium ulcerans | acetolactate synthase 1 catalytic subunit | 0.0224 | 0.34 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.95 nM | Antagonist activity at alpha6 nAChR in rat striatum assessed as inhibition of nicotine-induced [3H]dopamine release | ChEMBL. | 21147530 |
Imax (functional) | = 60 % | Antagonist activity at alpha6 nAChR in rat striatum assessed as inhibition of nicotine-induced [3H]dopamine release relative to nicotine | ChEMBL. | 21147530 |
Inhibition (functional) | = 50 % | Antagonist activity at alpha6 nAChR in rat striatum assessed as inhibition of nicotine-induced [3H]dopamine release at 100 nM relative to control | ChEMBL. | 21147530 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.